Published in
Elsevier, The Lancet Microbe, 9(3), p. e663-e671, 2022
DOI: 10.1016/s2666-5247(22)00126-4
Links
Tools
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
Journal article published in 2022 by
Daniel Jenkin,
Adam J. Ritchie,
Jeremy Aboagye,
Sofiya Fedosyuk,
Luke Thorley,
Samuel Provstgaad-Morys,
Helen Sanders,
Duncan Bellamy 
,
Rebecca Makinson ,
Zhi Quan Xiang,
Emma Bolam,
Richard Tarrant,
Fernando Ramos Lopez,
Abigail Platt,
Ian Poulton
and other authors.
,
Rebecca Makinson ,
Zhi Quan Xiang,
Emma Bolam,
Richard Tarrant,
Fernando Ramos Lopez,
Abigail Platt,
Ian Poulton
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 